GLP-1 drugs could cut mortality rates in US and UK, Swiss Re says
Reinsurance News - Sep 18, 2025
Swiss Re, a reinsurance company based in Zurich, has released new research suggesting that GLP-1 weight-loss medications could substantially reduce mortality rates in the United States and the United Kingdom over the next two decades. According to the company’s projections, if these drugs are widely...
Recommended Articles
Posted: Apr 16, 2026
Capgemini Research Institute, the research division of the Capgemini, has published the report Physi...
Posted: Apr 16, 2026
Beazley, a large specialist insurer, has announced plans to establish a new Marine War insurance con...
Posted: Apr 16, 2026
John Doyle, President and Chief Executive Officer (CEO) of global insurance and reinsurance broking...